These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 770131)

  • 41. Pruritus in Autoimmune Connective Tissue Diseases.
    Smith GP; Argobi Y
    Dermatol Clin; 2018 Jul; 36(3):267-275. PubMed ID: 29929598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Basic immunologic indices and their significance in the diagnosis of rheumatic diseases. II. Analysis of immunologic indices in individual rheumatic diseases].
    Timofeev VT
    Revmatologiia (Mosk); 1983; (4):48-54. PubMed ID: 6366975
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cardiac involvement in systemic autoimmune disease].
    Dropiński J; Szczeklik W; Rubiś P
    Pol Arch Med Wewn; 2003 Apr; 109(4):375-81. PubMed ID: 12931489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune rheumatic diseases in women.
    Schuna AA
    J Am Pharm Assoc (Wash); 2002; 42(4):612-23; quiz 623-4. PubMed ID: 12150360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects and side-effects of immunosuppressive therapy in various dermatoses (author's transl)].
    Metz G; Lurz C; Metz J
    MMW Munch Med Wochenschr; 1974 Jul; 116(28):1329-38. PubMed ID: 4212641
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drug therapy in collagen diseases].
    Brühl W
    Wiad Lek; 1971 Jul; 24(13):1279-83. PubMed ID: 4256585
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical study with a new phenylbutazone preparation in rheumatology].
    Marmont A; Rossi F
    Clin Ter; 1972 Oct; 63(1):17-51. PubMed ID: 4566104
    [No Abstract]   [Full Text] [Related]  

  • 48. Aggressive therapy for childhood rheumatic diseases. When are immunosuppressives appropriate?
    Lehman TJ
    Arthritis Rheum; 1993 Jan; 36(1):71-4. PubMed ID: 8424840
    [No Abstract]   [Full Text] [Related]  

  • 49. Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases.
    Filippini P; Del Papa N; Sambataro D; Del Bufalo A; Locatelli F; Rutella S
    Curr Med Chem; 2012; 19(31):5381-93. PubMed ID: 22963664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.
    Chighizola CB; Ong VH; Meroni PL
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):401-423. PubMed ID: 27515671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [HLA antigens and rheumatic diseases].
    Timofeev VT
    Vopr Revm; 1982; (4):53-64. PubMed ID: 6760543
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
    Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
    Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
    [No Abstract]   [Full Text] [Related]  

  • 53. Chloroquine and QTc interval.
    Silva JA; Silva MB; Skare TL
    Clin Exp Rheumatol; 2007; 25(5):795. PubMed ID: 18078640
    [No Abstract]   [Full Text] [Related]  

  • 54. B cell depletion therapy in rheumatic disease.
    Edwards JC; Cambridge G; Leandro MJ
    Best Pract Res Clin Rheumatol; 2006 Oct; 20(5):915-28. PubMed ID: 16980214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azathioprine for use in dermatology.
    Gendler E
    J Dermatol Surg Oncol; 1984 Jun; 10(6):462-4. PubMed ID: 6725741
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunosuppressive drugs in dermatology--benefits and threats.
    Kowal A; Warmińska J; Krasowska D
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):14-21. PubMed ID: 15323159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of severe systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis].
    Giebel S; Zoń-Giebel A; Błach A; Kucharz EJ; Hołowiecki J
    Pol Arch Med Wewn; 2003 Aug; 110(2):891-7. PubMed ID: 14682229
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease.
    Waterhouse JC; Perez TH; Albert PJ
    Ann N Y Acad Sci; 2009 Sep; 1173():757-65. PubMed ID: 19758226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New directions of pharmacotherapy of immune - inflammatory rheumatic diseases].
    Nasonov EL
    Ter Arkh; 2019 Aug; 91(8):98-107. PubMed ID: 32598760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.